GLP-1 Medication Misuse Raises Safety Concerns for Individuals with Eating Disorders

Researchers are highlighting a potential issue where individuals with eating disorders might be using GLP-1 weight-loss drugs improperly. This practice is contraindicated and is prompting worries about patient safety. The findings suggest a need for clearer clinical guidance regarding these medications.